Navigating the Whirlwind Surrounding N-Nitrosamine Impurities in APIs and Drug Products
October 1, 2025
FDA Practice Group Leader David Rosen is speaking in SAAMnow’s Fall Workshop in the session “Navigating the Whirlwind Surrounding N-Nitrosamine Impurities in APIs and Drug Products” on October 1.
The workshop will focus on regulatory, scientific, and technical challenges surrounding the presence of N-nitrosamine impurities in active pharmaceutical ingredients (APIs) and drug products. Participants will explore cutting-edge methods, regulatory updates, and research developments regarding N-nitrosamines.
The workshop will address:
- U.S. Food and Drug Administration (FDA) perspective on N-Nitrosamine Impurities,
- International Generic and Biosimilar Medicines Association (IGBA) perspective on nitrosamine impurities, the worldwide challenges,
- ICH M7 risk assessment and control of N-nitrosamine impurities,
- Over-the counter (OTC) drug products and their challenges with N-nitrosamine impurities, and
- Prescription drug products and their challenges with N-Nitrosamine impurities.
People
Related Insights
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…
December 3, 2025
Manufacturing Industry Advisor
Made in China: What the Automotive Industry Should Know About the Global Emergence of Chinese Manufacturing of Connected Vehicles Amid Increasing U.S. Restrictions
China’s automotive industry has gone global, in no small part due to technological advancements, cost advantages, and foreign investment through joint ventures, particularly in electric vehicle (“EV”) and connected vehicle technologies.
December 3, 2025
Foley In Fashion
How Tariffs Are Reshaping Holiday Shopping Trends for Fashion, Apparel & Beauty Brands
As the holiday rush approaches, tariffs have quickly become one of the most influential forces shaping retail strategies. A wave of updated import duties is driving up costs across apparel, accessories, cosmetics and beauty packaging – creating pressures many brands are already confronting as they prepare for peak retail months.